Extracorporeal Membrane Oxygenation for Influenza-Associated Acute Respiratory Distress Syndrome

Abstract

Background Extracorporeal membrane oxygenation (ECMO) therapy for patients with influenza A (H1N1)–related acute respiratory distress syndrome (ARDS) has been described once all other therapeutic options have been exhausted. The current report reviews our institutional experience and lessons learned in 18 consecutive patients.

Methods Between December 2009 and March 2011, 18 patients underwent ECMO therapy for severe H1N1-related ARDS. Mean age was 40 ± 18 years (range 4–67 years). Ten patients (56%) received venoarterial cannulation (v-a ECMO) while venovenous cannulation (v-v ECMO) was initiated in the remaining patients (n = 8, 44%). To identify risk factors of adverse outcome, univariate analysis was performed for clinical parameters.

Results Successful ECMO weaning was possible in 44% (n = 8) of patients and overall mortality was 61% (n = 11). Seven of the eight patients who could be successfully weaned from ECMO support fully recovered. Survival within the v-a ECMO group (60%) was superior to the v-v ECMO group (13%; p = 0.06). Two patients (11%) required re-exploration of the axillary artery cannulation site. No further adverse events associated with ECMO implantation occurred. Outcome was better when the time of severe deoxygenation (Pao ₂ < 70 mm Hg) despite maximally invasive respiratory support to ECMO implantation was less than 6 hours (odds ratio: 2.4; p = 0.05).

Conclusions ARDS associated with H1N1 remains a devastating clinical picture. In our hands, ECMO support offered survival to 40% of patients with otherwise fatal prognosis. While v-v ECMO remains the method of choice for patients suffering an isolated ARDS in the setting of stable hemodynamic conditions, v-a ECMO may be considered if the clinical picture of ARDS is aggravated by systemic inflammatory response syndrome with the requirement of high dose vasopressor support.

Keywords

circulatory assist devises - extracorporal membrane oxygenation (ECMO) - pulmonary function

• References

• 1 World Health Organization. Influenza A(H1N1) 2009 virus: current situation and post-pandemic recommendations. Wkly Epidemiol Rec 2011; 86 (8) 61-65
• 2 Narula T, Safley M, deBoisblanc BP. H1N1-associated acute respiratory distress syndrome. Am J Med Sci 2010; 340 (6) 499-504
• 3 Davies A, Jones D, Bailey M , et al; Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302 (17) 1888-1895
• 4 Extracorporeal Life Support Organization. H1N1 Specific Supplements to the ELSO General Guidelines. Extracorporeal Life Support Organization; 2009: 1-4
• 5 Yan TD, Poh CL, Martens-Nielsen J. Extracorporeal membrane oxygenation support in management of severe respiratory failure secondary to 2009 influenza A(H1N1) virus. Chest 2010; 138 (2) 455-456 , author reply 455–456
• 6 Kolla S, Awad SS, Rich PB, Schreiner RJ, Hirschl RB, Bartlett RH. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 1997; 226 (4) 544-564 , discussion 565–566
• 7 Stöhr F, Emmert MY, Lachat ML , et al. Extracorporeal membrane oxygenation for acute respiratory distress syndrome: is the configuration mode an important predictor for the outcome?. Interact Cardiovasc Thorac Surg 2011; 12 (5) 676-680
• 8 World Health Organization. New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009; 84 (25) 249-257
• 9 Novel Influenza A(H1N1) Investigation Team. Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Euro Surveill 2009; 14 (31) pii: 19295
• 10 Combes A, Pellegrino V. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1)-associated acute respiratory distress syndrome. Semin Respir Crit Care Med 2011; 32 (2) 188-194
• 11 Wong I, Vuylsteke A. Use of extracorporeal life support to support patients with acute respiratory distress syndrome due to H1N1/2009 influenza and other respiratory infections. Perfusion 2011; 26 (1) 7-20
• 12 Noah MA, Peek GJ, Finney SJ , et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306 (15) 1659-1668
• 13 Peek GJ, Mugford M, Tiruvoipati R , et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374 (9698) 1351-1363
• 14 Freed DH, Henzler D, White CW , et al; Canadian Critical Care Trials Group. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010; 57 (3) 240-247
• 15 Bisdas T, Beutel G, Warnecke G , et al. Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg 2011; 92 (2) 626-631
• 16 Meyer A, Strüber M, Fischer S. Advances in extracorporeal ventilation. Anesthesiol Clin 2008; 26 (2) 381-391 , viii
• 17 Egan TM, Duffin J, Glynn MF , et al. Ten-year experience with extracorporeal membrane oxygenation for severe respiratory failure. Chest 1988; 94 (4) 681-687
• 18 Kolobow T, Moretti MP, Fumagalli R , et al. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 1987; 135 (2) 312-315
• 19 Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137 (5) 1159-1164
• 20 Gofman JW, Jones HB. Obesity, fat metabolism and cardiovascular disease. Circulation 1952; 5 (4) 514-517
• 21 Yeh F, Dixon AE, Marion S , et al. Obesity in adults is associated with reduced lung function in metabolic syndrome and diabetes: the Strong Heart Study. Diabetes Care 2011; 34 (10) 2306-2313
• 22 Chahal H, McClelland RL, Tandri H , et al. Obesity and right ventricular structure and function: the MESA-Right Ventricle Study. Chest 2012; 141 (2) 388-395